Total Payments
$3,520
2023 Payments
$14.16
Companies
29
Transactions
179
Medicare Patients
5,148
Medicare Billing
$423,533
Payment Breakdown by Category
Food & Beverage$3,495 (99.3%)
Other$25.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,495 | 178 | 99.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $671.63 | 30 | $0 (2022) |
| ABBVIE INC. | $458.60 | 19 | $0 (2022) |
| PFIZER INC. | $442.61 | 21 | $0 (2022) |
| Lilly USA, LLC | $348.67 | 12 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $283.39 | 19 | $0 (2022) |
| GlaxoSmithKline, LLC. | $184.40 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $182.80 | 9 | $0 (2022) |
| Amgen Inc. | $164.60 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $92.38 | 7 | $0 (2022) |
| Abbott Laboratories | $64.61 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.16 | 1 | Insulet Corporation ($14.16) |
| 2022 | $757.28 | 40 | ABBVIE INC. ($221.28) |
| 2021 | $1,063 | 51 | AbbVie Inc. ($224.64) |
| 2020 | $272.05 | 13 | Lilly USA, LLC ($141.10) |
| 2019 | $269.89 | 13 | Amgen Inc. ($100.00) |
| 2018 | $538.55 | 26 | Novo Nordisk Inc ($188.70) |
| 2017 | $605.08 | 35 | Novo Nordisk Inc ($188.58) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/23/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Insulin Pump | ||||||
| 12/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 11/05/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Diabetes | ||||||
| 10/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Cardio-renal | ||||||
| 09/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Inflammation | ||||||
| 08/05/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/01/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $15.31 | General |
| Category: Endocrinology | ||||||
| 07/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 07/12/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: PSYCHIATRY | ||||||
| 06/24/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.11 | General |
| 05/24/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $95.25 | General |
| Category: VACCINES | ||||||
| 05/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: VACCINES | ||||||
| 05/09/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 29 | 1,612 | 2,701 | $296,056 | $138,985 |
| 2021 | 30 | 1,825 | 2,958 | $323,198 | $161,440 |
| 2020 | 31 | 1,711 | 2,799 | $270,414 | $123,107 |
Total Patients
5,148
Total Services
8,458
Medicare Billing
$423,533
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 509 | $83,985 | $37,216 | 44.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 183 | 183 | $25,986 | $22,410 | 86.2% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 146 | 168 | $36,960 | $19,873 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 211 | $25,401 | $10,710 | 42.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 95 | 198 | $24,750 | $8,886 | 35.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 137 | $19,188 | $7,131 | 37.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 91 | 91 | $9,737 | $6,237 | 64.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 79 | 149 | $10,132 | $4,226 | 41.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 17 | $6,494 | $3,535 | 54.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 27 | $6,750 | $2,715 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 95 | 95 | $4,940 | $2,591 | 52.4% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 23 | 26 | $6,500 | $2,486 | 38.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 21 | $4,200 | $1,646 | 39.2% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2022 | 20 | 31 | $3,565 | $1,551 | 43.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 26 | 28 | $3,920 | $1,386 | 35.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 23 | $4,930 | $945.88 | 19.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 19 | 19 | $1,558 | $847.08 | 54.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 28 | 85 | $4,675 | $779.08 | 16.7% |
| 99347 | Established patient home visit, typically 15 minutes | Office | 2022 | 11 | 15 | $1,350 | $586.10 | 43.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 12 | 17 | $986.00 | $567.90 | 57.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $988.00 | $521.21 | 52.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 54 | $1,782 | $516.23 | 29.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 12 | 13 | $2,470 | $401.40 | 16.3% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 92 | 92 | $1,104 | $396.68 | 35.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 100 | 124 | $1,612 | $365.40 | 22.7% |
About Dr. Donald Ebersole, MD
Dr. Donald Ebersole, MD is a Family Medicine healthcare provider based in Everett, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932179587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Ebersole, MD has received a total of $3,520 in payments from pharmaceutical and medical device companies, with $14.16 received in 2023. These payments were reported across 179 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,495).
As a Medicare-enrolled provider, Ebersole has provided services to 5,148 Medicare beneficiaries, totaling 8,458 services with total Medicare billing of $423,533. Data is available for 3 years (2020–2022), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Everett, WA
- Active Since 01/25/2006
- Last Updated 12/10/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1932179587
Products in Payments
- VRAYLAR (Drug) $314.87
- Ozempic (Drug) $242.27
- Victoza (Drug) $229.75
- XARELTO (Drug) $224.05
- TRULICITY (Drug) $204.73
- ENTRESTO (Drug) $182.80
- UBRELVY (Drug) $145.96
- ELIQUIS (Drug) $139.31
- RYBELSUS (Drug) $112.90
- Repatha (Biological) $100.00
- ADVAIR (Drug) $97.88
- PREVNAR 20 (Biological) $95.25
- EUCRISA (Drug) $93.85
- Otezla (Drug) $64.60
- INVOKANA (Drug) $59.34
- JARDIANCE (Drug) $58.53
- Kerendia (Drug) $55.72
- FreeStyle Libre 2 (Device) $50.94
- TRELEGY ELLIPTA (Drug) $49.96
- BELSOMRA (Drug) $48.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Everett
Dr. Simi Kohli, M.d., M.sc, M.D., M.SC
Family Medicine — Payments: $4,866
Family Medicine $4,866
Albert Yuen, Md, MD
Family Medicine — Payments: $3,915
Family Medicine $3,915
Dr. Vincent Koike, D.o, D.O
Family Medicine — Payments: $3,241
Family Medicine $3,241
David Lindstrom, Md, MD
Family Medicine — Payments: $3,167
Family Medicine $3,167
Dr. Tushar Garg, Do, DO
Family Medicine — Payments: $1,849
Family Medicine $1,849
Sara Nelson, Md, MD
Family Medicine — Payments: $1,466
Family Medicine $1,466